The prevalence of thyroid cancer has been rapidly increasing in the last two decades, with a notable number of cases being identified as small, clinically concealed papillary cancers. This rise in thyroid cancer is largely attributed to advancements in diagnostic capabilities, particularly in the detection of small nodules. The ambiguity surrounding fine-needle aspiration (FNA) outcomes and the necessity for frozen-section pathology have created a critical demand for a more precise and minimally invasive tool for diagnosing thyroid nodules. The Thyroid Nodule Impedance Measurement System (TN-IMS) device is an innovative electrical impedance-based system that addresses this requirement.
The Efficiency of Thyroid Nodule Impedance Measurement System in Thyroid Cancer
The Thyroid Nodule Impedance Measurement System (TN-IMS) is an innovative system that utilizes electrical impedance to measure thyroid nodules. This cutting-edge technology effectively meets the demand for accurate thyroid nodule impedance measurements.
The TN-IMS device utilizes electrical impedance spectroscopy (EIS) to measure two electrical impedance features of thyroid nodules – Z1kHz and IPS. These measurements help distinguish between malignant/high-risk nodules requiring excision and low-risk nodules needing follow-up. The system has been fully calibrated using histopathological results from a cohort study of several patients, providing a precise and real-time diagnostic solution for thyroid nodules.
the new Hospitech Thyroid Nodule Impedance Measurement System is transforming thyroid cancer diagnosis by providing real-time, highly accurate detection of high-risk nodules. This system aims to improve patient outcomes by reducing unnecessary surgeries.
Result of Thyroid Nodule Impedance Measurement System in Clinical Study
The system has been evaluated for performance using sensitivity, specificity, and accuracy metrics. The system has demonstrated a sensitivity of 94%, indicating its ability to detect 94% of actual positive cases (detectable nodules in radiology and surgery). The specificity has been 87%, signifying its capability to correctly identify 87% of negative cases (normal thyroid and colloid goiter), and the overall accuracy has been 91%, reflecting its ability to accurately diagnose 91% of the samples. The evaluation has revealed a high level of accuracy in detecting thyroid nodules using the Thyroid Nodule Impedance Measurement System (TN-IMS) device. A total of 48 detectable nodules have been identified in radiology, 3 in surgery, and 3 undetectable nodules have been missed in both radiology and surgery. Furthermore, 36 samples have been determined to have normal thyroid/colloid goiter. In total, the TN-IMS device has analyzed 90 samples.
Hospitech Thyroid Nodule Impedance Measurement System
Hospitech Cancer Care Innovations is at the forefront of revolutionizing cancer diagnosis with its advanced range of devices. These include the Cancer Diagnostic Probe (CDP), Impedimetric Tumor Detection System (ITDS), Electrical Endoscopy Mass Detection (EMD), and ElectroChemoTherapy (ECT) & Gamma Probe . The Thyroid Nodule Impedance Measurement System (TN-IMS) is a state-of-the-art technology aimed at enhancing thyroid cancer detection and treatment effectiveness. Backed by research, publications, and patents, these tools deliver precise results for early diagnosis and improved patient outcomes. The company prides itself on its dedicated team and steadfast commitment to making a meaningful impact in the healthcare industry’s battle against cancer.
Elevate your medical facility with Hospitech’s Thyroid Nodule Impedance Measurement System and experience a cutting-edge and secure approach to thyroid cancer surgery and treatment.
